{"transactions":[{"id":784611,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":48315,"kind":"organization","name":"Matrix Capital Management Company, LP","position":1,"cik":"0001410830","reported_name":"Matrix Capital Management Company, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":48316,"kind":"person","name":"GOEL DAVID E.","position":2,"cik":"0001548144","reported_name":"GOEL DAVID E.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.00001 per share (Common Stock)","published_at":"2026-05-11T20:16:00.000Z","date":"2026-05-07","kind":"sale","planned":false,"acquired":false,"shares":6922870,"price":5.64,"value":39044986.8,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported herein are held by Matrix Capital Management Master Fund, LP (the \"Matrix Fund\"). Matrix Capital Management Company, LP (the \"Investment Manager\"), a Delaware limited partnership, is the investment advisor to the Matrix Fund. Mr. David E. Goel (\"Mr. Goel\", and together with the Investment Manager, the \"Reporting Persons\"), serves as the Managing General Partner of the Investment Manager."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The filing of this statement shall not be deemed an admission that either of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950142-26-001346","document":"es260777872_4-matrix.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410830/000095014226001346/es260777872_4-matrix.xml","form_type":"4"}},{"id":969513,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":48315,"kind":"organization","name":"Matrix Capital Management Company, LP","position":1,"cik":"0001410830","reported_name":"Matrix Capital Management Company, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":48316,"kind":"person","name":"GOEL DAVID E.","position":2,"cik":"0001548144","reported_name":"GOEL DAVID E.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2025-12-15T22:24:17.000Z","date":"2025-12-15","kind":"sale","planned":false,"acquired":false,"shares":7500000,"price":1.33,"value":9975000.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported herein are held by Matrix Capital Management Master Fund, LP (the \"Matrix Fund\"). Matrix Capital Management Company, LP (the \"Investment Manager\"), a Delaware limited partnership, is the investment advisor to the Matrix Fund. Mr. David E. Goel (\"Mr. Goel\", and together with the Investment Manager, the \"Reporting Persons\"), serves as the Managing General Partner of the Investment Manager."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The filing of this statement shall not be deemed an admission that either of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein."}],"balance_after":6459973,"source":{"system":"sec-edgar","filing":"0000902664-25-005288","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000090266425005288/ownership.xml","form_type":"4"}},{"id":1745635,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":48315,"kind":"organization","name":"Matrix Capital Management Company, LP","position":1,"cik":"0001410830","reported_name":"Matrix Capital Management Company, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":48316,"kind":"person","name":"GOEL DAVID E.","position":2,"cik":"0001548144","reported_name":"GOEL DAVID E.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.00001 per share (Common Stock)","published_at":"2023-11-09T21:35:45.000Z","date":"2023-11-09","kind":"purchase","planned":false,"acquired":true,"shares":1560000,"price":9,"value":14040000.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported herein are held by Matrix Capital Management Master Fund, LP (the \"Matrix Fund\"). Matrix Capital Management Company, LP (the \"Investment Manager\"), a Delaware limited partnership, is the investment advisor to the Matrix Fund. Mr. David E. Goel (\"Mr. Goel\", and together with the Investment Manager, the \"Reporting Persons\"), serves as the Managing General Partner of the Investment Manager."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The filing of this statement shall not be deemed an admission that either of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein."}],"balance_after":6922870,"source":{"system":"sec-edgar","filing":"0000902664-23-005429","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410830/000090266423005429/ownership.xml","form_type":"4"}},{"id":1849629,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":48315,"kind":"organization","name":"Matrix Capital Management Company, LP","position":1,"cik":"0001410830","reported_name":"Matrix Capital Management Company, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":48316,"kind":"person","name":"GOEL DAVID E.","position":2,"cik":"0001548144","reported_name":"GOEL DAVID E.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2023-06-20T20:30:54.000Z","date":"2023-06-20","kind":"purchase","planned":false,"acquired":true,"shares":4760000,"price":22.66,"value":107861600.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported herein are held by Matrix Capital Management Master Fund, LP (the \"Matrix Fund\"). Matrix Capital Management Company, LP (the \"Investment Manager\"), a Delaware limited partnership, is the investment advisor to the Matrix Fund. Mr. David E. Goel (\"Mr. Goel\", and together with the Investment Manager, the \"Reporting Persons\"), serves as the Managing General Partner of the Investment Manager."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The filing of this statement shall not be deemed an admission that either of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein."}],"balance_after":13959973,"source":{"system":"sec-edgar","filing":"0000902664-23-003642","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000090266423003642/ownership.xml","form_type":"4"}},{"id":2093194,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":48315,"kind":"organization","name":"Matrix Capital Management Company, LP","position":1,"cik":"0001410830","reported_name":"Matrix Capital Management Company, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":48316,"kind":"person","name":"GOEL DAVID E.","position":2,"cik":"0001548144","reported_name":"GOEL DAVID E.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.00001 per share (\"Common Stock\")","published_at":"2022-12-07T21:30:57.000Z","date":"2022-12-05","kind":"purchase","acquired":true,"shares":1250000,"price":12,"value":15000000.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported herein are held by Matrix Capital Management Master Fund, LP (the \"Matrix Fund\"). Matrix Capital Management Company, LP (the \"Investment Manager\"), a Delaware limited partnership, is the investment advisor to the Matrix Fund. Mr. David E. Goel (\"Mr. Goel\", and together with the Investment Manager, the \"Reporting Persons\"), serves as the Managing General Partner of the Investment Manager."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The filing of this statement shall not be deemed an admission that either of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein."}],"balance_after":5362870,"source":{"system":"sec-edgar","filing":"0000902664-22-005061","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410830/000090266422005061/ownership.xml","form_type":"4"}},{"id":2524434,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":48315,"kind":"organization","name":"Matrix Capital Management Company, LP","position":1,"cik":"0001410830","reported_name":"Matrix Capital Management Company, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":48316,"kind":"person","name":"GOEL DAVID E.","position":2,"cik":"0001548144","reported_name":"GOEL DAVID E.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series E Convertible Preferred Stock","published_at":"2021-11-04T20:44:54.000Z","date":"2021-11-02","kind":"exercise","acquired":false,"shares":2327870,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series E Convertible Preferred Stock was convertible at any time, at the holder's election on a 1-for-1 basis, and did not have an expiration date. The shares of Series E Convertible Preferred Stock automatically converted into shares of Common Stock on a 1-for-1 basis upon the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series E Convertible Preferred Stock was convertible at any time, at the holder's election on a 1-for-1 basis, and did not have an expiration date. The shares of Series E Convertible Preferred Stock automatically converted into shares of Common Stock on a 1-for-1 basis upon the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series E Convertible Preferred Stock was convertible at any time, at the holder's election on a 1-for-1 basis, and did not have an expiration date. The shares of Series E Convertible Preferred Stock automatically converted into shares of Common Stock on a 1-for-1 basis upon the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities reported herein are held by Matrix Capital Management Master Fund, LP (the \"Matrix Fund\"). Matrix Capital Management Company, LP (the \"Investment Manager\"), a Delaware limited partnership, is the investment advisor to the Matrix Fund. Mr. David E. Goel (\"Mr. Goel\", and together with the Investment Manager, the \"Reporting Persons\"), serves as the Managing General Partner of the Investment Manager."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The filing of this statement shall not be deemed an admission that either of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2327870},"source":{"system":"sec-edgar","filing":"0000902664-21-004738","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1410830/000090266421004738/ownership.xml","form_type":"4"}},{"id":2524433,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":48315,"kind":"organization","name":"Matrix Capital Management Company, LP","position":1,"cik":"0001410830","reported_name":"Matrix Capital Management Company, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":48316,"kind":"person","name":"GOEL DAVID E.","position":2,"cik":"0001548144","reported_name":"GOEL DAVID E.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-11-04T20:44:54.000Z","date":"2021-11-02","kind":"purchase","acquired":true,"shares":1785000,"price":14,"value":24990000.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities reported herein are held by Matrix Capital Management Master Fund, LP (the \"Matrix Fund\"). Matrix Capital Management Company, LP (the \"Investment Manager\"), a Delaware limited partnership, is the investment advisor to the Matrix Fund. Mr. David E. Goel (\"Mr. Goel\", and together with the Investment Manager, the \"Reporting Persons\"), serves as the Managing General Partner of the Investment Manager."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The filing of this statement shall not be deemed an admission that either of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein."}],"balance_after":4112870,"source":{"system":"sec-edgar","filing":"0000902664-21-004738","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1410830/000090266421004738/ownership.xml","form_type":"4"}},{"id":2524432,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":48315,"kind":"organization","name":"Matrix Capital Management Company, LP","position":1,"cik":"0001410830","reported_name":"Matrix Capital Management Company, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":48316,"kind":"person","name":"GOEL DAVID E.","position":2,"cik":"0001548144","reported_name":"GOEL DAVID E.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.00001 per share (\"Common Stock\")","published_at":"2021-11-04T20:44:54.000Z","date":"2021-11-02","kind":"exercise","acquired":true,"shares":2327870,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series E Convertible Preferred Stock was convertible at any time, at the holder's election on a 1-for-1 basis, and did not have an expiration date. The shares of Series E Convertible Preferred Stock automatically converted into shares of Common Stock on a 1-for-1 basis upon the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities reported herein are held by Matrix Capital Management Master Fund, LP (the \"Matrix Fund\"). Matrix Capital Management Company, LP (the \"Investment Manager\"), a Delaware limited partnership, is the investment advisor to the Matrix Fund. Mr. David E. Goel (\"Mr. Goel\", and together with the Investment Manager, the \"Reporting Persons\"), serves as the Managing General Partner of the Investment Manager."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The filing of this statement shall not be deemed an admission that either of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein."}],"balance_after":2327870,"source":{"system":"sec-edgar","filing":"0000902664-21-004738","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410830/000090266421004738/ownership.xml","form_type":"4"}},{"id":2796903,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":48316,"kind":"person","name":"GOEL DAVID E.","position":1,"cik":"0001548144","reported_name":"GOEL DAVID E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}},{"id":48315,"kind":"organization","name":"Matrix Capital Management Company, LP","position":2,"cik":"0001410830","reported_name":"Matrix Capital Management Company, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}}],"security":"Common Stock","published_at":"2021-03-11T00:45:24.000Z","date":"2021-03-10","kind":"sale","acquired":false,"shares":30268,"price":42.3769,"value":1282664.0092,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $42.01 to $42.685, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"The securities reported herein are held by Matrix Capital Management Master Fund, LP (the \"Matrix Fund\"). Matrix Capital Management Company, LP (the\n \"Investment Manager\"), a Delaware limited partnership, is the investment advisor to the Matrix Fund. Mr. David E. Goel (\"Mr. Goel\", and together with the\n Investment Manager, the \"Reporting Persons\"), serves as the Managing General Partner of the Investment Manager."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F11","text":"The filing of this statement shall not be deemed an admission that either of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein."}],"balance_after":12309090,"source":{"system":"sec-edgar","filing":"0000902664-21-001835","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000090266421001835/ownership.xml","form_type":"4"}},{"id":2796902,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":48316,"kind":"person","name":"GOEL DAVID E.","position":1,"cik":"0001548144","reported_name":"GOEL DAVID E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}},{"id":48315,"kind":"organization","name":"Matrix Capital Management Company, LP","position":2,"cik":"0001410830","reported_name":"Matrix Capital Management Company, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}}],"security":"Common Stock","published_at":"2021-03-11T00:45:24.000Z","date":"2021-03-10","kind":"sale","acquired":false,"shares":25732,"price":41.4673,"value":1067036.5636,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $41 to $42, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"The securities reported herein are held by Matrix Capital Management Master Fund, LP (the \"Matrix Fund\"). Matrix Capital Management Company, LP (the\n \"Investment Manager\"), a Delaware limited partnership, is the investment advisor to the Matrix Fund. Mr. David E. Goel (\"Mr. Goel\", and together with the\n Investment Manager, the \"Reporting Persons\"), serves as the Managing General Partner of the Investment Manager."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F11","text":"The filing of this statement shall not be deemed an admission that either of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein."}],"balance_after":12339358,"source":{"system":"sec-edgar","filing":"0000902664-21-001835","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000090266421001835/ownership.xml","form_type":"4"}},{"id":2796901,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":48316,"kind":"person","name":"GOEL DAVID E.","position":1,"cik":"0001548144","reported_name":"GOEL DAVID E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}},{"id":48315,"kind":"organization","name":"Matrix Capital Management Company, LP","position":2,"cik":"0001410830","reported_name":"Matrix Capital Management Company, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}}],"security":"Common Stock","published_at":"2021-03-11T00:45:24.000Z","date":"2021-03-09","kind":"sale","acquired":false,"shares":34302,"price":41.1605,"value":1411887.471,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $41.005 to $41.66, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"The securities reported herein are held by Matrix Capital Management Master Fund, LP (the \"Matrix Fund\"). Matrix Capital Management Company, LP (the\n \"Investment Manager\"), a Delaware limited partnership, is the investment advisor to the Matrix Fund. Mr. David E. Goel (\"Mr. Goel\", and together with the\n Investment Manager, the \"Reporting Persons\"), serves as the Managing General Partner of the Investment Manager."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F11","text":"The filing of this statement shall not be deemed an admission that either of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein."}],"balance_after":12365090,"source":{"system":"sec-edgar","filing":"0000902664-21-001835","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000090266421001835/ownership.xml","form_type":"4"}},{"id":2796900,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":48316,"kind":"person","name":"GOEL DAVID E.","position":1,"cik":"0001548144","reported_name":"GOEL DAVID E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}},{"id":48315,"kind":"organization","name":"Matrix Capital Management Company, LP","position":2,"cik":"0001410830","reported_name":"Matrix Capital Management Company, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}}],"security":"Common Stock","published_at":"2021-03-11T00:45:24.000Z","date":"2021-03-09","kind":"sale","acquired":false,"shares":215698,"price":40.4238,"value":8719332.8124,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $40 to $41, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"The securities reported herein are held by Matrix Capital Management Master Fund, LP (the \"Matrix Fund\"). Matrix Capital Management Company, LP (the\n \"Investment Manager\"), a Delaware limited partnership, is the investment advisor to the Matrix Fund. Mr. David E. Goel (\"Mr. Goel\", and together with the\n Investment Manager, the \"Reporting Persons\"), serves as the Managing General Partner of the Investment Manager."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F11","text":"The filing of this statement shall not be deemed an admission that either of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein."}],"balance_after":12399392,"source":{"system":"sec-edgar","filing":"0000902664-21-001835","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000090266421001835/ownership.xml","form_type":"4"}},{"id":2796899,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":48316,"kind":"person","name":"GOEL DAVID E.","position":1,"cik":"0001548144","reported_name":"GOEL DAVID E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}},{"id":48315,"kind":"organization","name":"Matrix Capital Management Company, LP","position":2,"cik":"0001410830","reported_name":"Matrix Capital Management Company, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}}],"security":"Common Stock","published_at":"2021-03-11T00:45:24.000Z","date":"2021-03-08","kind":"sale","acquired":false,"shares":85911,"price":41.6216,"value":3575753.2776,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $41.495, to $41.945, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"The securities reported herein are held by Matrix Capital Management Master Fund, LP (the \"Matrix Fund\"). Matrix Capital Management Company, LP (the\n \"Investment Manager\"), a Delaware limited partnership, is the investment advisor to the Matrix Fund. Mr. David E. Goel (\"Mr. Goel\", and together with the\n Investment Manager, the \"Reporting Persons\"), serves as the Managing General Partner of the Investment Manager."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F11","text":"The filing of this statement shall not be deemed an admission that either of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein."}],"balance_after":12615090,"source":{"system":"sec-edgar","filing":"0000902664-21-001835","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000090266421001835/ownership.xml","form_type":"4"}},{"id":2796898,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":48316,"kind":"person","name":"GOEL DAVID E.","position":1,"cik":"0001548144","reported_name":"GOEL DAVID E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}},{"id":48315,"kind":"organization","name":"Matrix Capital Management Company, LP","position":2,"cik":"0001410830","reported_name":"Matrix Capital Management Company, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}}],"security":"Common Stock","published_at":"2021-03-11T00:45:24.000Z","date":"2021-03-08","kind":"sale","acquired":false,"shares":71194,"price":41.2063,"value":2933641.3222,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $40.49 to $41.49, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"The securities reported herein are held by Matrix Capital Management Master Fund, LP (the \"Matrix Fund\"). Matrix Capital Management Company, LP (the\n \"Investment Manager\"), a Delaware limited partnership, is the investment advisor to the Matrix Fund. Mr. David E. Goel (\"Mr. Goel\", and together with the\n Investment Manager, the \"Reporting Persons\"), serves as the Managing General Partner of the Investment Manager."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F11","text":"The filing of this statement shall not be deemed an admission that either of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein."}],"balance_after":12701001,"source":{"system":"sec-edgar","filing":"0000902664-21-001835","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000090266421001835/ownership.xml","form_type":"4"}},{"id":2796897,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":48316,"kind":"person","name":"GOEL DAVID E.","position":1,"cik":"0001548144","reported_name":"GOEL DAVID E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}},{"id":48315,"kind":"organization","name":"Matrix Capital Management Company, LP","position":2,"cik":"0001410830","reported_name":"Matrix Capital Management Company, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}}],"security":"Common Stock","published_at":"2021-03-11T00:45:24.000Z","date":"2021-03-08","kind":"sale","acquired":false,"shares":33600,"price":39.9714,"value":1343039.04,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $39.845 to $40.465, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"The securities reported herein are held by Matrix Capital Management Master Fund, LP (the \"Matrix Fund\"). Matrix Capital Management Company, LP (the\n \"Investment Manager\"), a Delaware limited partnership, is the investment advisor to the Matrix Fund. Mr. David E. Goel (\"Mr. Goel\", and together with the\n Investment Manager, the \"Reporting Persons\"), serves as the Managing General Partner of the Investment Manager."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F11","text":"The filing of this statement shall not be deemed an admission that either of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein."}],"balance_after":12772195,"source":{"system":"sec-edgar","filing":"0000902664-21-001835","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000090266421001835/ownership.xml","form_type":"4"}},{"id":2796896,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":48316,"kind":"person","name":"GOEL DAVID E.","position":1,"cik":"0001548144","reported_name":"GOEL DAVID E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}},{"id":48315,"kind":"organization","name":"Matrix Capital Management Company, LP","position":2,"cik":"0001410830","reported_name":"Matrix Capital Management Company, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}}],"security":"Common Stock","published_at":"2021-03-11T00:45:24.000Z","date":"2021-03-08","kind":"sale","acquired":false,"shares":75000,"price":39.2155,"value":2941162.5,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $38.83 to $39.83, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"The securities reported herein are held by Matrix Capital Management Master Fund, LP (the \"Matrix Fund\"). Matrix Capital Management Company, LP (the\n \"Investment Manager\"), a Delaware limited partnership, is the investment advisor to the Matrix Fund. Mr. David E. Goel (\"Mr. Goel\", and together with the\n Investment Manager, the \"Reporting Persons\"), serves as the Managing General Partner of the Investment Manager."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F11","text":"The filing of this statement shall not be deemed an admission that either of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein."}],"balance_after":12805795,"source":{"system":"sec-edgar","filing":"0000902664-21-001835","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000090266421001835/ownership.xml","form_type":"4"}},{"id":2796895,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":48316,"kind":"person","name":"GOEL DAVID E.","position":1,"cik":"0001548144","reported_name":"GOEL DAVID E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}},{"id":48315,"kind":"organization","name":"Matrix Capital Management Company, LP","position":2,"cik":"0001410830","reported_name":"Matrix Capital Management Company, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}}],"security":"Common Stock","published_at":"2021-03-11T00:45:24.000Z","date":"2021-03-08","kind":"sale","acquired":false,"shares":234295,"price":38.2181,"value":8954309.7395,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $37.8275 to $38.825, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"The securities reported herein are held by Matrix Capital Management Master Fund, LP (the \"Matrix Fund\"). Matrix Capital Management Company, LP (the\n \"Investment Manager\"), a Delaware limited partnership, is the investment advisor to the Matrix Fund. Mr. David E. Goel (\"Mr. Goel\", and together with the\n Investment Manager, the \"Reporting Persons\"), serves as the Managing General Partner of the Investment Manager."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F11","text":"The filing of this statement shall not be deemed an admission that either of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein."}],"balance_after":12880795,"source":{"system":"sec-edgar","filing":"0000902664-21-001835","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000090266421001835/ownership.xml","form_type":"4"}},{"id":3077712,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":48316,"kind":"person","name":"GOEL DAVID E.","position":1,"cik":"0001548144","reported_name":"GOEL DAVID E.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":48315,"kind":"organization","name":"Matrix Capital Management Company, LP","position":2,"cik":"0001410830","reported_name":"Matrix Capital Management Company, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}}],"security":"Common Stock","published_at":"2020-07-22T20:15:48.000Z","date":"2020-07-20","kind":"sale","acquired":false,"shares":2000000,"price":40,"value":80000000.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported herein are held by Matrix Capital Management Master Fund, LP (the \"Matrix Fund\"). Matrix Capital Management Company, LP (the \"Investment Manager\"), a Delaware limited partnership, is the investment advisor to the Matrix Fund. Mr. David E. Goel (\"Mr. Goel\", and together with the Investment Manager, the \"Reporting Persons\"), serves as the Managing General Partner of the Investment Manager."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The filing of this statement shall not be deemed an admission that either of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein."}],"balance_after":13115090,"source":{"system":"sec-edgar","filing":"0000902664-20-002761","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000090266420002761/ownership.xml","form_type":"4"}},{"id":3300102,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":48316,"kind":"person","name":"GOEL DAVID E.","position":1,"cik":"0001548144","reported_name":"GOEL DAVID E.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":48315,"kind":"organization","name":"Matrix Capital Management Company, LP","position":2,"cik":"0001410830","reported_name":"Matrix Capital Management Company, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}}],"security":"Common Stock","published_at":"2020-01-28T21:15:37.000Z","date":"2020-01-24","kind":"exercise","acquired":false,"shares":2217101,"price":26.5,"value":58753176.5,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported herein are held by Matrix Capital Management Master Fund, LP (the \"Matrix Fund\"). Matrix Capital Management Company, LP (the \"Investment Manager\"), a Delaware limited partnership, is the investment advisor to the Matrix Fund. Mr. David E. Goel (\"Mr. Goel\", and together with the Investment Manager, the \"Reporting Persons\"), serves as the Managing General Partner of the Investment Manager."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The filing of this statement shall not be deemed an admission that either of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein."}],"balance_after":15115090,"source":{"system":"sec-edgar","filing":"0000902664-20-000523","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000090266420000523/ownership.xml","form_type":"4"}},{"id":3471250,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":48316,"kind":"person","name":"GOEL DAVID E.","position":1,"cik":"0001548144","reported_name":"GOEL DAVID E.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":48315,"kind":"organization","name":"Matrix Capital Management Company, LP","position":2,"cik":"0001410830","reported_name":"Matrix Capital Management Company, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}}],"security":"Series F-1 Convertible Preferred Stock","published_at":"2019-07-02T21:53:56.000Z","date":"2019-07-01","kind":"exercise","acquired":false,"shares":84359,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All of the shares of convertible preferred stock automatically converted into shares of the Issuer's common stock upon the closing of the Issuer's initial public offering. The convertible preferred stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"All of the shares of convertible preferred stock automatically converted into shares of the Issuer's common stock upon the closing of the Issuer's initial public offering. The convertible preferred stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities reported herein are held by Matrix Capital Management Master Fund, LP (the \"Matrix Fund\"). Matrix Capital Management Company, LP (the \"Investment Manager\"), a Delaware limited partnership, is the investment advisor to the Matrix Fund. Mr. David E. Goel (\"Mr. Goel\", and together with the Investment Manager, the \"Reporting Persons\"), serves as the Managing General Partner of the Investment Manager."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The filing of this statement shall not be deemed an admission that either of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":10.6686,"underlying":"Common Stock","underlying_shares":84359},"source":{"system":"sec-edgar","filing":"0000902664-19-002915","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000090266419002915/ownership.xml","form_type":"4"}},{"id":3471249,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":48316,"kind":"person","name":"GOEL DAVID E.","position":1,"cik":"0001548144","reported_name":"GOEL DAVID E.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":48315,"kind":"organization","name":"Matrix Capital Management Company, LP","position":2,"cik":"0001410830","reported_name":"Matrix Capital Management Company, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}}],"security":"Series F Convertible Preferred Stock","published_at":"2019-07-02T21:53:56.000Z","date":"2019-07-01","kind":"exercise","acquired":false,"shares":11154116,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All of the shares of convertible preferred stock automatically converted into shares of the Issuer's common stock upon the closing of the Issuer's initial public offering. The convertible preferred stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"All of the shares of convertible preferred stock automatically converted into shares of the Issuer's common stock upon the closing of the Issuer's initial public offering. The convertible preferred stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities reported herein are held by Matrix Capital Management Master Fund, LP (the \"Matrix Fund\"). Matrix Capital Management Company, LP (the \"Investment Manager\"), a Delaware limited partnership, is the investment advisor to the Matrix Fund. Mr. David E. Goel (\"Mr. Goel\", and together with the Investment Manager, the \"Reporting Persons\"), serves as the Managing General Partner of the Investment Manager."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The filing of this statement shall not be deemed an admission that either of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":8.9653,"underlying":"Common Stock","underlying_shares":11154116},"source":{"system":"sec-edgar","filing":"0000902664-19-002915","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000090266419002915/ownership.xml","form_type":"4"}},{"id":3471248,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":48316,"kind":"person","name":"GOEL DAVID E.","position":1,"cik":"0001548144","reported_name":"GOEL DAVID E.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":48315,"kind":"organization","name":"Matrix Capital Management Company, LP","position":2,"cik":"0001410830","reported_name":"Matrix Capital Management Company, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}}],"security":"Series E-1 Convertible Preferred Stock","published_at":"2019-07-02T21:53:56.000Z","date":"2019-07-01","kind":"exercise","acquired":false,"shares":5893716,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All of the shares of convertible preferred stock automatically converted into shares of the Issuer's common stock upon the closing of the Issuer's initial public offering. The convertible preferred stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"All of the shares of convertible preferred stock automatically converted into shares of the Issuer's common stock upon the closing of the Issuer's initial public offering. The convertible preferred stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities reported herein are held by Matrix Capital Management Master Fund, LP (the \"Matrix Fund\"). Matrix Capital Management Company, LP (the \"Investment Manager\"), a Delaware limited partnership, is the investment advisor to the Matrix Fund. Mr. David E. Goel (\"Mr. Goel\", and together with the Investment Manager, the \"Reporting Persons\"), serves as the Managing General Partner of the Investment Manager."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The filing of this statement shall not be deemed an admission that either of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":6.0389,"underlying":"Common Stock","underlying_shares":5893716},"source":{"system":"sec-edgar","filing":"0000902664-19-002915","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000090266419002915/ownership.xml","form_type":"4"}},{"id":3471247,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":48316,"kind":"person","name":"GOEL DAVID E.","position":1,"cik":"0001548144","reported_name":"GOEL DAVID E.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":48315,"kind":"organization","name":"Matrix Capital Management Company, LP","position":2,"cik":"0001410830","reported_name":"Matrix Capital Management Company, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}}],"security":"Series A Convertible Preferred Stock","published_at":"2019-07-02T21:53:56.000Z","date":"2019-07-01","kind":"exercise","acquired":false,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All of the shares of convertible preferred stock automatically converted into shares of the Issuer's common stock upon the closing of the Issuer's initial public offering. The convertible preferred stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"All of the shares of convertible preferred stock automatically converted into shares of the Issuer's common stock upon the closing of the Issuer's initial public offering. The convertible preferred stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities reported herein are held by Matrix Capital Management Master Fund, LP (the \"Matrix Fund\"). Matrix Capital Management Company, LP (the \"Investment Manager\"), a Delaware limited partnership, is the investment advisor to the Matrix Fund. Mr. David E. Goel (\"Mr. Goel\", and together with the Investment Manager, the \"Reporting Persons\"), serves as the Managing General Partner of the Investment Manager."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The filing of this statement shall not be deemed an admission that either of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":1,"underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0000902664-19-002915","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000090266419002915/ownership.xml","form_type":"4"}},{"id":3471246,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":48316,"kind":"person","name":"GOEL DAVID E.","position":1,"cik":"0001548144","reported_name":"GOEL DAVID E.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":48315,"kind":"organization","name":"Matrix Capital Management Company, LP","position":2,"cik":"0001410830","reported_name":"Matrix Capital Management Company, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}}],"security":"Common Stock","published_at":"2019-07-02T21:53:56.000Z","date":"2019-07-01","kind":"exercise","acquired":true,"shares":84359,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"All of the shares of convertible preferred stock automatically converted into shares of the Issuer's common stock upon the closing of the Issuer's initial public offering. The convertible preferred stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities reported herein are held by Matrix Capital Management Master Fund, LP (the \"Matrix Fund\"). Matrix Capital Management Company, LP (the \"Investment Manager\"), a Delaware limited partnership, is the investment advisor to the Matrix Fund. Mr. David E. Goel (\"Mr. Goel\", and together with the Investment Manager, the \"Reporting Persons\"), serves as the Managing General Partner of the Investment Manager."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The filing of this statement shall not be deemed an admission that either of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein."}],"balance_after":17332191,"source":{"system":"sec-edgar","filing":"0000902664-19-002915","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000090266419002915/ownership.xml","form_type":"4"}},{"id":3471245,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":48316,"kind":"person","name":"GOEL DAVID E.","position":1,"cik":"0001548144","reported_name":"GOEL DAVID E.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":48315,"kind":"organization","name":"Matrix Capital Management Company, LP","position":2,"cik":"0001410830","reported_name":"Matrix Capital Management Company, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}}],"security":"Common Stock","published_at":"2019-07-02T21:53:56.000Z","date":"2019-07-01","kind":"exercise","acquired":true,"shares":11154116,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"All of the shares of convertible preferred stock automatically converted into shares of the Issuer's common stock upon the closing of the Issuer's initial public offering. The convertible preferred stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities reported herein are held by Matrix Capital Management Master Fund, LP (the \"Matrix Fund\"). Matrix Capital Management Company, LP (the \"Investment Manager\"), a Delaware limited partnership, is the investment advisor to the Matrix Fund. Mr. David E. Goel (\"Mr. Goel\", and together with the Investment Manager, the \"Reporting Persons\"), serves as the Managing General Partner of the Investment Manager."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The filing of this statement shall not be deemed an admission that either of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein."}],"balance_after":17247832,"source":{"system":"sec-edgar","filing":"0000902664-19-002915","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000090266419002915/ownership.xml","form_type":"4"}},{"id":3471244,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":48316,"kind":"person","name":"GOEL DAVID E.","position":1,"cik":"0001548144","reported_name":"GOEL DAVID E.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":48315,"kind":"organization","name":"Matrix Capital Management Company, LP","position":2,"cik":"0001410830","reported_name":"Matrix Capital Management Company, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}}],"security":"Common Stock","published_at":"2019-07-02T21:53:56.000Z","date":"2019-07-01","kind":"exercise","acquired":true,"shares":5893716,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"All of the shares of convertible preferred stock automatically converted into shares of the Issuer's common stock upon the closing of the Issuer's initial public offering. The convertible preferred stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities reported herein are held by Matrix Capital Management Master Fund, LP (the \"Matrix Fund\"). Matrix Capital Management Company, LP (the \"Investment Manager\"), a Delaware limited partnership, is the investment advisor to the Matrix Fund. Mr. David E. Goel (\"Mr. Goel\", and together with the Investment Manager, the \"Reporting Persons\"), serves as the Managing General Partner of the Investment Manager."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The filing of this statement shall not be deemed an admission that either of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein."}],"balance_after":6093716,"source":{"system":"sec-edgar","filing":"0000902664-19-002915","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000090266419002915/ownership.xml","form_type":"4"}},{"id":3471243,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":48316,"kind":"person","name":"GOEL DAVID E.","position":1,"cik":"0001548144","reported_name":"GOEL DAVID E.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":48315,"kind":"organization","name":"Matrix Capital Management Company, LP","position":2,"cik":"0001410830","reported_name":"Matrix Capital Management Company, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}}],"security":"Common Stock","published_at":"2019-07-02T21:53:56.000Z","date":"2019-07-01","kind":"exercise","acquired":true,"shares":200000,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"All of the shares of convertible preferred stock automatically converted into shares of the Issuer's common stock upon the closing of the Issuer's initial public offering. The convertible preferred stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities reported herein are held by Matrix Capital Management Master Fund, LP (the \"Matrix Fund\"). Matrix Capital Management Company, LP (the \"Investment Manager\"), a Delaware limited partnership, is the investment advisor to the Matrix Fund. Mr. David E. Goel (\"Mr. Goel\", and together with the Investment Manager, the \"Reporting Persons\"), serves as the Managing General Partner of the Investment Manager."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The filing of this statement shall not be deemed an admission that either of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein."}],"balance_after":200000,"source":{"system":"sec-edgar","filing":"0000902664-19-002915","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000090266419002915/ownership.xml","form_type":"4"}}]}